3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
5
Hematologic Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Weight Cycling
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Substance-Related Disorders
1
Smoldering Multiple Myeloma
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Motor Activity
1
Mental Disorders
1
Insulin Resistance
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Head and Neck Carcinoma
1
Genital Neoplasms, Female
1
Interventions
Paclitaxel
6
pembrolizumab
3
Cisplatin
3
Carboplatin
3
Biopsy
3
adavosertib
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Fulvestrant
2
Doxorubicin
2
ulixertinib
1
tucatinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
sacituzumab govitecan
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
niraparib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Behavior Therapy
×
1 year
×
Clear all
No trials found.